Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Accounts Payables (2016 - 2025)

INVO Fertility has reported Accounts Payables over the past 16 years, most recently at $2.4 million for Q3 2025.

  • Quarterly Accounts Payables fell 9.94% to $2.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Sep 2025, down 9.94% year-over-year, with the annual reading at $3.1 million for FY2024, 33.61% up from the prior year.
  • Accounts Payables was $2.4 million for Q3 2025 at INVO Fertility, up from $2.2 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $4.8 million in Q1 2025 and troughed at $306252.0 in Q2 2021.
  • The 5-year median for Accounts Payables is $1.8 million (2023), against an average of $1.7 million.
  • Year-over-year, Accounts Payables surged 299.65% in 2023 and then fell 9.94% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $443422.0 in 2021, then skyrocketed by 204.23% to $1.3 million in 2022, then surged by 72.74% to $2.3 million in 2023, then soared by 33.61% to $3.1 million in 2024, then decreased by 23.2% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Accounts Payables are $2.4 million (Q3 2025), $2.2 million (Q2 2025), and $4.8 million (Q1 2025).